ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
2018 · Molecular Cancer Therapeutics · 138 citations
https://doi.org/10.1158/1535-7163.mct-16-0847
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
262
Citations
5
h-index
5
i10-index
Alexander Bondke is an academic researcher from Imperial College London. The author has contributed to research in topics: Cancer-related Molecular Pathways & Advanced Breast Cancer Therapies & Cytokine Signaling Pathways and Interactions. The author has an h-index of 5, co-authored 25 publications.
https://doi.org/10.1158/1535-7163.mct-16-0847
https://doi.org/10.1038/s41467-024-46375-9
Click to start Chat